Catalyst Wire Dossier Catalyst Wire Dossier

REGN1908-1909

· Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN1908-1909, covering 2014-06-10 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy [Phase 3]

See pricing